Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.505 USD | +1.01% | -4.94% | +17.37% |
May. 21 | Erasca Closes Oversubscribed Share Offering to Raise $184 Million | MT |
May. 17 | Erasca Acquires 2 Exclusive Worldwide Licenses for Preclinical RAS Programs | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.37% | 676M | |
+43.01% | 58.06B | |
-6.29% | 40.53B | |
+37.52% | 38.99B | |
+13.44% | 26.7B | |
-12.56% | 26.56B | |
-21.94% | 18.98B | |
-0.35% | 12.17B | |
+23.48% | 12B | |
+24.39% | 11.92B |
- Stock Market
- Equities
- ERAS Stock
- News Erasca, Inc.
- Erasca Says US FDA Grants Orphan Drug Designation for ERAS-801 for Malignant Glioma